Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2022-05-10 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
祥生医疗独立董事关于第二届董事会第十二次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a specific board meeting agenda item related to the granting of restricted stock under a 2021 stock incentive plan. It references compliance with company articles, securities laws, and stock exchange rules. The content focuses on governance and approval of stock incentives rather than financial results or audit information. The document length is short (1411 characters) and it is not a full report but an opinion on a board matter. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management, including stock incentive plans.
2022-05-10 Chinese
上海荣正投资咨询股份有限公司关于无锡祥生医疗科技股份有限公司2021年限制性股票激励计划预留授予相关事项之独立财务顾问报告
Capital/Financing Update Classification · 95% confidence The document is an Independent Financial Advisor Report related to a 2021 restricted stock incentive plan for Wuxi Xiangsheng Medical Technology Co., Ltd. It details the approval procedures, grant conditions, grant details, and the impact on financials. The document is comprehensive, over 7,000 characters, and contains detailed financial and procedural information about the stock incentive plan. It is not a simple announcement or a brief summary but a detailed advisory report. The content focuses on the stock incentive plan and its financial implications, which aligns with a Capital/Financing Update category rather than a general regulatory filing or announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-05-10 Chinese
上海市通力律师事务所关于无锡祥生医疗科技股份有限公司2021年限制性股票激励计划预留部分限制性股票授予事项的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's 2021 restricted stock incentive plan reserved portion stock grant. It discusses the legal compliance, approvals, authorizations, and conditions related to the stock incentive plan and its reserved stock grant. The document is not a financial report, earnings release, or management discussion. It is a legal proceeding related to stock incentive matters, involving regulatory compliance and approvals. Therefore, it fits best under Legal Proceedings Report (LTR). The document length is 6522 characters, which is substantive and contains detailed legal analysis, not just an announcement or certification.
2022-05-10 Chinese
祥生医疗关于向激励对象授予预留部分限制性股票的公告
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding the granting of reserved restricted shares (限制性股票) to incentive recipients by Wuxi Xiangsheng Medical Technology Co., Ltd. It details the decision-making process, approval by the board and supervisory committee, the number of shares granted, the price, the recipients, and legal and financial advisor opinions. The content focuses on a share-based incentive plan and the issuance of shares to employees or management. This is a capital change event related to share issuance under an employee stock incentive plan. It is not a full financial report, audit report, or earnings release. It is not a proxy or voting result announcement. It is a formal announcement of a share issue related to stock incentives. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (7170 characters) and detailed content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2022-05-10 Chinese
祥生医疗2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the Annual General Meeting (AGM) of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the date and location of the AGM, attendance, voting results on various proposals including the 2021 annual report, board work report, remuneration plans, audit firm appointment, profit distribution, financial budget, credit application, and other matters. The document includes voting percentages and confirms the legality and validity of the meeting and voting process, witnessed by lawyers. The content is focused on the official announcement of the AGM resolutions and voting outcomes rather than the full annual report or financial statements themselves. The document length is relatively short (3241 characters) and it serves as a formal announcement of the AGM decisions and voting results. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-05-10 Chinese
祥生医疗第二届监事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th meeting of the 2nd Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the approval of granting restricted stock incentives to certain employees under the 2021 restricted stock incentive plan. The document includes meeting attendance, legal compliance statements, and voting results. It does not contain financial statements or detailed financial data but rather reports on corporate governance decisions related to stock incentives. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company management or board bodies. The document length is short (1690 characters), and it is not a report or announcement of a report publication, so it is not RPA or RNS. Therefore, the best classification is MANG with high confidence.
2022-05-10 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.